Intravenous solid tip ECG lead placement in telemetry implanted dogs. Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.

Journal of Pharmacological and Toxicological Methods

Volumn 68, Issue 1, 2013, Pages 62-73

  Mitchell, Andrea Z ^a   Bills, Andrew J ^a   Wittwer, Gary T ^a   Foley, C Michael ^a   Kremer, John J ^a   Chen, Hepei ^a   Osinski, Mark A ^a  

^a 206 Carnegie Center   (United States)

Author keywords

Cardiovascular; Dogs; ECG; Preclinical; Surgical methods; Telemetry

Indexed keywords

MILRINONE; MOXIFLOXACIN; SOTALOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM; DOG; DRUG EFFECT; ELECTROCARDIOGRAM; ELECTRODE IMPLANT; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FUNCTION; HEART RATE; JUGULAR VEIN; MALE; MEDICAL DEVICE; NONHUMAN; POWER ANALYSIS; PR INTERVAL; QRS COMPLEX; QT INTERVAL; RETROSPECTIVE POWER ANALYSIS; SENSITIVITY ANALYSIS; TELEMETRY;

CARDIOVASCULAR; DOGS; ECG; PRECLINICAL; SURGICAL METHODS; TELEMETRY;

ANIMALS; AZA COMPOUNDS; DOGS; ELECTROCARDIOGRAPHY; ELECTRODES, IMPLANTED; HEART RATE; HEMODYNAMICS; JUGULAR VEINS; LONG QT SYNDROME; MALE; MILRINONE; QUINOLINES; SENSITIVITY AND SPECIFICITY; SOTALOL; TELEMETRY; TOXICITY TESTS; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; CANIS FAMILIARIS;

EID: 84880041507     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2013.04.006     Document Type: Article

References (41)

1. Authier S., Moon L.B., Stonerook M., Fournier S., Gervais J., Maghezzi S., et al. Evaluation of a novel ECG lead placement method in telemetered freely moving cynomolgus monkeys: Assessment of an intravascular biopotential lead. Journal of Pharmacological and Toxicological Methods 2011, 64:145-150.
2. Authier S., Tanguay J.F., Gauvin D., Di Fruscia R., Fournier S. A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 2: Pharmacological validation. Journal of Pharmacological and Toxicological Methods 2007, 56:122-130.
3. Authier S., Tanguay J.F., Gauvin D., Di Fruscia R., Fournier S., Chaurand F., et al. A cardiovascular monitoring system in conscious cynomolgus monkeys for regulatory safety pharmacology. Part 1: Non-pharmacological validation. Journal of Pharmacological and Toxicological Methods 2007, 56:115-121.
4. Chaves A.A., Zingaro G.J., Yordy M.A., Bustard K.A., O'Sullivan S., Galijatovic-Idrizbegovic A., et al. A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol, and MK-499. Journal of Pharmacological and Toxicological Methods 2007, 56:103-114.
5. Chiang A.Y., Smith W.C., Main B.W., Sarazan R.D. Statistical power analysis for hemodynamic cardiovascular safety pharmacology studies in beagle dogs. Journal of Pharmacological and Toxicological Methods 2004, 50:121-130.
6. Cools F., Janssens S., Vanlommel A., Teisman A., Towart R., Gallacher D.J. ECG arrhythmias in non-implanted vs. telemetry-implanted dogs: Need for screening before and sufficient recovery time after implantation. Journal of Pharmacological and Toxicological Methods 2011, 64:60-67.
7. Detweiler D.K. The dog electrocardiogram: A critical review. Comprehensive electrocardiography: Theory and practice in health and disease 1989, Vol. 2:1267-1327. Pergamon Press, New York, New York, (Ch. 35). P.W. MacFarlane, T.D.V. Lawrie (Eds.).
8. Detweiler D.K. Electrocardiography in toxicological studies. Comprehensive toxicology 1997, Vol. 6:95-115. Elsevier Science Ltd., Oxford, United Kingdom, (Ch. 6.07). I.G. Sipes (Ed.).
9. Douglas C.L., Beck T.W., Walisser J.A., Foley C.M., Kremer J.J., Sarazan R.D. Moxifloxacin in conscious dogs with epicardial ECG leads and semi-automated scoring. Journal of Pharmacological and Toxicological Methods 2010, 62:e28.
10. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. Journal of American Statistics Association 1955, 50:1096-1121.
11. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics 1964, 20:482-491.
12. Gauvin D.V., Tilley L.P., Smith F.W.K., Baird T.J. Electrocardiogram, hemodynamics, and core body temperatures of the normal free moving laboratory beagle dog by remote radiotelemetry. Journal of Pharmacological and Toxicological Methods 2006, 53:128-139.
13. Gauvin D.V., Tilley L.P., Smith F.W.K., Baird T.J. Electrocardiogram, hemodynamics, and core body temperatures of the normal free moving cynomolgus monkey by remote radiotelemetry. Journal of Pharmacological and Toxicological Methods 2006, 53:140-151.
14. Guth B.D., Bass A.S., Briscoe R., Chivers S., Markert M., Siegl P.K.S., et al. Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies. Journal of Pharmacological and Toxicological Methods 2009, 560:107-116.
15. Hamlin R.L. How many leads are required for in vivo studies in safety pharmacology?. Journal of Pharmacological and Toxicological Methods 2008, 57:161-168.
16. max - A measure of 'baroinometry'. Journal of Pharmacological and Toxicological Methods 2012, 66:63-65.
17. Hanton G., Gautier M., Bonnet P., Herbet A. Effect of milrinone on echocardiographic parameters after single dose in beagle dogs and relationship with drug-induced cardiotoxicity. Toxicology Letters 2005, 155(2):307-317.
18. Hartford C.G., Marcos E.F., Rogers G.C. Noninvasive versus invasive blood pressure measurement in normotensive and hypertensive baboons. Laboratory Animal Science 1996, 46:231-233.
19. Henriques T.A., Beck T.W., Douglas C.L., Jones H.M., Kremer J.J., Kruzich P.J., et al. Left thoracotomy surgical approach for chronic instrumentation in dogs and monkeys providing high-quality electrocardiogram signals. Journal of Pharmacological and Toxicological Methods 2010, 62:136-142.
20. Hsu J.C. Multiple comparisons: Theory and methods 1996, Chapman & Hall, London, England.
21. ICH.S7A Guidance Safety pharmacology studies for human pharmaceuticals 2001.
22. ICH.S7B Guidance The nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals 2005.
23. Kurtz T.W., Grifflin K.A., Bidani A.K., Davisson R.L., Hall J.E. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45:299-310.
24. Leishman D.J., Beck T.W., Dybdal N., Gallacher D.J., Guth B.D., Holbrook M., et al. Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: Current recommendations from the Safety Pharmacology Society. Journal of Pharmacological and Toxicological Methods 2012, 65:93-101.
25. Littell R.C., Stroup W.W., Freund R.J. SAS for linear models 2002, John Wiley & Sons Inc., New York, NY. 4th ed.
26. McCullagh P., Nelder J.A. Generalized linear models 1989, Chapman and Hall, London, England. 2nd ed.
27. Mittelstadt S.W., Hart S.M. Effects of moxifloxacin on QT interval in conscious dogs. Journal of Veterinary Pharmacology and Therapeutics 2005, 28(3):253-256.
28. Prior H., McMahon N., Schofield J., Valentin J.-P. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs. Journal of Pharmacological and Toxicological Methods 2009, 60:167-173.
29. Ringer L.W., Austin-LaFrance R., Gorczyca W.P., Wolfgang E.A., Wisialowski T.A., Steidl J. Effects of milrinone on myocardial contractility across different species. Journal of Pharmacological and Toxicological Methods 2011, 64:e28.
30. Russell W.M.S., Burch R.L. The principles of humane experimental technique 1959, Methuen & Co. Ltd., London.
31. max in nonclinical drug safety assessment studies. Journal of Pharmacological and Toxicological Methods 2012, 66:71-78.
32. Singer D., Stonerook M., Vinci T., Hassler C., Vadnal A. Telemetric intracardiac ECG dramatically improve internal detection and reduces artifact when compared to a subcutaneous lead placement in freely moving dogs. The FASEB Journal 2006, 20:A232.
33. Soloviev M.V., Hamlin R.L., Barrett R.M., Schaefer G.J. Different species require different correction factors for the QT interval. Cardiovascular Toxicology 2006, 06:145-157.
34. Soloviev M.V., Hamlin R.L., Shellhammer L.J., Barrett R.M., Wally R.A., Birchmeier P.A., et al. Variations in hemodynamic parameters and ECG in healthy, conscious, freely moving telemetrized beagle dogs. Cardiovascular Toxicology 2006, 06:51-62.
35. Spence S., Soper K., Hoe C.-M., Coleman J. The heart rate-corrected QT interval of conscious beagle dogs: A formula based on analysis of covariance. Toxicological Sciences 1998, 45:247-258.
36. Tattersall M.L., Dymond M., Hammond T., Valentin J.-P. Correction of QT values to allow for increases in heart rate in conscious beagle dogs in toxicology assessment. Journal of Pharmacological and Toxicological Methods 2006, 53:11-19.
37. Thakur A.K. Statistical issues in large animal toxicology. International Journal of Toxicology 2000, 19:133-140.
38. Tilley L.P., Smith F.W.K. Electrocardiography. Manual of canine and feline cardiology 2008, 49-77. Saunders Elsevier, St. Louis, Missouri, (Ch. 3). 4th ed. L.P. Tilley (Ed.).
39. Winer B.J., Brown D.R., Michels K.M. Single-factor experiments having repeated measures on the same elements. Statistical principles in experimental design 1991, 220-281. McGraw-Hill, New York, New York, (Ch. 4). 3rd ed.
40. Winer B.J., Brown D.R., Michels K.M. Analysis of covariance. Statistical principles in experimental design 1991, 739-836. McGraw-Hill, New York, New York, (Ch. 10). 3rd ed.
41. Yao J.-A., Feldman H.S., Illenberger A., Littell T., Schnee L., Yates D. Evaluation of electrocardiograms recorded in cynomolgus monkeys with short- and long-term intracardiac lead implantations. Journal of Pharmacological and Toxicological Methods 2009, 60:185-192.